← Insider buys
NKTR

Nektar Therapeutics · Healthcare

SVP and Chief Commercial Officer John Northcott sold $86K of Nektar Therapeutics

Sold$85,635
$13.83Price
6,192Shares
−3%Stake

What NKTR did after the filing

Prices for NKTR after this filing aren't in yet.

Traded Mon, Aug 16. Filed Wed, Aug 18, 2:59 PM ET, during the session. Not investment advice.